377 related articles for article (PubMed ID: 30477198)
1. Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
Martin Lluesma S; Graciotti M; Chiang CL; Kandalaft LE
Vaccines (Basel); 2018 Nov; 6(4):. PubMed ID: 30477198
[TBL] [Abstract][Full Text] [Related]
2. Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?
Martin-Lluesma S; Graciotti M; Grimm AJ; Boudousquié C; Chiang CL; Kandalaft LE
Curr Opin Biotechnol; 2020 Oct; 65():190-196. PubMed ID: 32334152
[TBL] [Abstract][Full Text] [Related]
3. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell vaccination in melanoma patients: From promising results to future perspectives.
Boudewijns S; Bloemendal M; Gerritsen WR; de Vries IJ; Schreibelt G
Hum Vaccin Immunother; 2016 Oct; 12(10):2523-2528. PubMed ID: 27322496
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell targeting vaccine for HPV-associated cancer.
Yin W; Duluc D; Joo H; Oh S
Cancer Cell Microenviron; 2016; 3(4):. PubMed ID: 28133621
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
8. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunotherapy using dendritic cells against multiple myeloma.
Nguyen-Pham TN; Lee YK; Lee HJ; Kim MH; Yang DH; Kim HJ; Lee JJ
Korean J Hematol; 2012 Mar; 47(1):17-27. PubMed ID: 22479274
[TBL] [Abstract][Full Text] [Related]
10. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.
Anguille S; Lion E; Van den Bergh J; Van Acker HH; Willemen Y; Smits EL; Van Tendeloo VF; Berneman ZN
Hum Vaccin Immunother; 2013 Sep; 9(9):1956-61. PubMed ID: 23778748
[TBL] [Abstract][Full Text] [Related]
12. Hydrogel/nanoadjuvant-mediated combined cell vaccines for cancer immunotherapy.
Yang A; Bai Y; Dong X; Ma T; Zhu D; Mei L; Lv F
Acta Biomater; 2021 Oct; 133():257-267. PubMed ID: 34407475
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer.
Ragde H; Cavanagh WA; Tjoa BA
J Urol; 2004 Dec; 172(6 Pt 2):2532-8. PubMed ID: 15538202
[TBL] [Abstract][Full Text] [Related]
14. RNA-loaded dendritic cells: more than a
Joshi A; Tandel N; Tyagi P; Dalai SK; Bisen PS; Tyagi RK
Immunotherapy; 2019 Sep; 11(13):1129-1147. PubMed ID: 31390917
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-based vaccine research against cancer.
Mody N; Dubey S; Sharma R; Agrawal U; Vyas SP
Expert Rev Clin Immunol; 2015 Feb; 11(2):213-32. PubMed ID: 25467734
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic dendritic cell-based cancer vaccines: the state of the art.
Strioga MM; Felzmann T; Powell DJ; Ostapenko V; Dobrovolskiene NT; Matuskova M; Michalek J; Schijns VE
Crit Rev Immunol; 2013; 33(6):489-547. PubMed ID: 24266347
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils in Dendritic Cell-Based Cancer Vaccination: The Potential Roles of Neutrophil Extracellular Trap Formation.
Chan L; Wood GA; Wootton SK; Bridle BW; Karimi K
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674412
[TBL] [Abstract][Full Text] [Related]
18. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell fusion vaccines for cancer immunotherapy.
Rosenblatt J; Kufe D; Avigan D
Expert Opin Biol Ther; 2005 May; 5(5):703-15. PubMed ID: 15934845
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
